UCLA Vine Street Clinic launches COVID Vaccine Trial

The UCLA Vine Street Clinic has begun enrollment in the Moderna trial. This is one of several studies seeking a vaccine for SARS-CoV-2, also known as COVID-19.

The purpose of this study is to test Moderna’s vaccine candidate (mRNA-1273) to see if it can prevent illness in people who are exposed to the SARS-CoV-2 virus in their everyday lives. This vaccine is not made from the SARS-CoV-2 virus. It is made from messenger ribonucleic acid (mRNA), a genetic code that tells cells how to make protein, which helps the body’s immune system make antibodies that can fight the virus. The vaccine cannot cause COVID-19 infection.

This Phase 3 trial is being conducted at multiple clinic sites across the U.S. with a goal of enrolling 30,000 patients. Trial participants will receive 2 injections, approximately 28 days apart, and will complete regular follow ups over the course of two years via phone calls, on-line surveys and additional in-person visits. The trial is coordinated through the newly formed COVID-19 Prevention Network. More info can be found here: https://www.coronaviruspreventionnetwork.org/ or visit our Active Research page.

About

CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.